Elsevier Announces the Anxiety and Depression: 21st Neuropharmacology Conference
Oxford, 9 March 2011 - Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced that the Anxiety and Depression: 21st Neuropharmacology Annual Conference will take place in Virginia, USA on 10-11 November 2011 as a satellite to the 2011 Meeting of the Society for Neuroscience.
Anxiety and depression are amongst the most common brain disorders, with significant consequences for the individual and society. The 21st Neuropharmacology annual conference will bring together the leading experts in the field of psychiatry, neuroscience and pharmacology to present and discuss the latest research.
The scientific committee composed of acknowledged opinion leaders in anxiety and depression from across the spectrum of research areas will work alongside organizers from Elsevier to develop a multidisciplinary programme.
“The 21st Neuropharmacology Conference on Anxiety and Depression provides researchers with a marvelous opportunity to share knowledge and network with their peers,” said Michael Osuch, executive publisher at Elsevier.
Among the topics covered at the Anxiety and Depression Conference are:
* Emerging Therapeutic Targets in Depression
* Emerging Therapeutic Targets in Anxiety
* Animal Models
* Genetics and Epigenetics in Depression and Anxiety
* Developmental Aspects of Anxiety and Depression
* Neuronal Circuits Underlying Anxiety and Depression
* Fear Extinction
* Mechanism of Action of Antidepressants and Anxiolytics
Attendees are welcome to register at www.neuropharmacology-conference.elsevier.com
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
+44 (0) 1865 843244